406275 - GlaxoSmithKline

Drug Profile

406275 - GlaxoSmithKline

Alternative Names: 362115; 362115A; 406725; 406725A

Latest Information Update: 21 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Analgesics; Antimigraines
  • Mechanism of Action Gap junction modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Epilepsy; Migraine; Neuropathic pain

Most Recent Events

  • 25 Nov 2004 Phase-I clinical trials in Neuropathic Pain in United Kingdom (unspecified route)
  • 16 Jan 2004 Phase-I clinical trials in Epilepsy in United Kingdom (unspecified route)
  • 16 Jan 2004 Phase-I clinical trials in Migraine in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top